Mass media: Pharmaceutical company reported about death of two children during treatment by the preparation Zolgensma

@Rossijskaja gazeta
Show original
Two children were lost as a result of treatment by the preparation Zolgensma. About it reports information agency "Reuters" with reference to the statement of the Swiss manufacturing company of medicine Novartis Int AG ". Two fatal cases of sharp hepatic insufficiency occurred to Russian Federation and Kazakhstan after 5-6 weeks of infusion of "Zolgensma" and approximately in 1-10 days after the beginning of gradual decrease in a dose of corticosteroids", - is spoken in the message. Ministry of Health of the Russian Federation registered Zolgensma at the end of 2021. In July of the 2022nd the preparation arrived in a civil turn. It was noted that drugs already used three packings Morozovskaya...
Analysis
×
Denis Manturov
Last position: Vice-chairman (Government of the Russian Federation)
124
Novartis Int AG
Main activity:Health care and social services
10
Center Health of Children
Companies
Минпромторг
Government Agency